Latest News
& Press Releases
Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.
TOP STORIES
BigHat Biosciences will team up with Merck to design candidates for three drug discovery programs backed by the company’s proprietary AI technology platform.
BMS is terminating a seven-year-old gene therapy collaboration to develop potential treatments for congestive heart failure with uniQure N.V. valued at $1 billion.
With $96 million in Series A financing, Cajal Neuroscience launched Tuesday to develop drug candidates to target neurodegeneration in Alzheimer’s and Parkinson’s diseases.
As the FDA cracks down on accelerated approvals, Genentech, a Roche company, voluntarily withdrew its monoclonal antibody, Tecentriq, for metastatic bladder cancer.
AstraZeneca and Neogene have entered into a definitive acquisition agreement in which AstraZeneca will buy all outstanding equity in the smaller company.
The U.S. Space Force’s Space Launch Delta 30 at Vandenberg Space Force Base has awarded Amentum a $59 million contract
The U.S. Department of Treasury’s Office of Terrorism and Financial intelligence (TFI) has selected Amentum, under its METIS Solutions entity, to provide a full range of
Amentum has been awarded a 5th consecutive environmental services contract to support the Pennsylvania Department of Environmental Protection (PADEP)
Amentum’s Liberty Village team recently received the International Stability Operations Association’s Vanguard Global Achievement Award in recognition of
Amentum has been awarded a $126 million, five-year contract by the U.S. Air Force for the Defense Technical Information Center (DTIC)
Amentum has been recognized as a Top 25 Veteran Employer for 2022 by the Veteran Employment Project, the jobs arm of Military.com
A second patient death has been linked to the Phase III clinical trial of Eisai and Biogen’s investigational Alzheimer’s drug lecanemab, according to the journal Science.
